https://www.selleckchem.com/products/ctpi-2.html
9 (95% CI, 10.1-11.8) compared with 5.3 (95% CI, 4.7-5.8) among cancer-free persons (P.0001). Overall, 92 patients with glioma (25%) and 30 cancer-free persons (6%) had moderate-to-severe depressive symptoms. After adjustment for marital status, education level, and comorbidity, the prevalence of depressive symptoms was 5 times higher among patients with glioma compared with cancer-free persons. A substantially higher prevalence of moderate-to-severe depressive symptoms was identified in patients with glioma compared with cancer-free
Like
Comment
Share
